For Industry

Overview

York and Scarborough Teaching Hospitals NHS Foundation Trust has a long history of working with Industry and Clinical Research Organisations to deliver research studies successfully and to a high standard.

We are committed to having an industry portfolio that is appropriate in both complexity and variety to march our Trust's geographical population and size.  Most of the studies we participate in take place at our three larger hospital sites: York Hospital, Scarborough General Hospital, and Bridlington District Hospital.

We have collaborated with Industry on Phase II to Phase V studies and each year we continue to build upon out performance and portfolio.

We have two clinical rooms to deliver research at York and Scarborough Hospital and have a dedicated commercial delivery team that will increase our capacity to run commercial trials.

We are collaborating with our local GP practice network allowing for more commercial research to take place in the region.

Specialties that currently support commercial research trials: Ophthalmology, Dermatology, Renal, Oncology, Perioperative care and ICU, and Gastroenterology

Industry acknowledgements and notable achievements

• Over the past 12 months we have had one Global 1^st, a European 1^st and a UK 1^st recruits to commercial studies.
• In 2024, we set up a commercial study in 30 days from selection date.
• Successful delivery of the Phase 3 COVID-19 vaccine trial COVLP-021, recruiting to target with 54 healthy volunteers. Utilised local and regional media to support the campaign, and delivered at a newly setup, trial-specific Vaccine Hub at the University of York by the R&I Department.
• In 2022, we ran a paediatric RSV vaccine trial and recruited to time and target.
• In 2019 we undertook our first independent GMO vaccine, Phase 2, Class 1 study for patient undergoing Kidney Transplantation.  Our previous experience of GMO vaccine trials has been through collaborations with our associated Medical School/University.
• The PuraStat^® post-market study into a device used to manage bleeding in vascular surgery patients recruited nearly triple the noted target within a 9-month period.
• Over the past 6 years industry has sponsored 7 investigator initiated research studies (single and multicentre) in the following areas: Ophthalmology, Perioperative care and ICU, Dentistry and Gastroenterology.
• Our participation in Arquer 006 contributed to the recruitment of 84 patients across North Yorkshire which was almost double that of the specified target.

Our current Trust performance data can be viewed here

Our Workforce

Our research workforce has a robust and varied skill set each with their own areas of specialism.

• Commercial Research Manager
• Dedicated Pharmacy Clinical Trials Team (4 members of staff)
• Dedicated Laboratory Clinical Trials Team (2 members of staff)
• Established links and access to the Trust's Radiology and Cardiorespiratory Departments
• We have more than 100 experienced Principle Investigators in the Trust
• Dedicated team of Research Nurses, Clinical Trials Assistants and Research Practitioners

Our Facilities

• Dedicated clinical research rooms at York and Scarborough Teaching Hospitals
• HSE Class 1 premises clearance to enable us to run studies involving Genetically Modified Organisms.
• Dedicated R&I laboratory and pharmacy rooms.

Quality Assurance

We also host an in-house R&I Quality Assurance team who are available to offer advice or internal monitoring to the Research Team to ensure a high quality of study delivery and data quality.

Further Information

If you would like us to conduct preliminary feasibility or if you have any other questions about collaborating with York and Scarborough Teaching Hospitals NHS Foundation Trust, please contact our Commercial Research Manager.

Marthe Ludtmann, PhD

Tel: 07747763555

Email: marthe.ludtmann1@nhs.net